Citadel Advisors’s Genelux GNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding GNLX
WDC
VCM
BL
FLPIM
VFT
CM
Citadel Advisors's GNLX Position: Q1 2026 in Review
Citadel Advisors sold out of Genelux (GNLX) in Q1 2026, closing a stake of 19,415 shares — an estimated $84.6K sold.
Citadel Advisors first reported a position in GNLX in Q1 2023 and held it in 8 quarters. The position peaked at $294K in Q1 2023. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.
- Citadel Advisors reported no remaining Genelux position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 19,415 Genelux shares in Q1 2026, an estimated $84.6K.
- Citadel Advisors first reported a position in Genelux in Q1 2023 and held it in 8 quarters.
- Citadel Advisors's Genelux position peaked at $294K in Q1 2023.
- 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.